RT Journal Article
SR Electronic
T1 Incorporating Human Movement Data to Improve Epidemiological Estimates for 2019-nCoV
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.07.20021071
DO 10.1101/2020.02.07.20021071
A1 Cao, Zhidong
A1 Zhang, Qingpeng
A1 Lu, Xin
A1 Pfeiffer, Dirk
A1 Wang, Lei
A1 Song, Hongbing
A1 Pei, Tao
A1 Jia, Zhongwei
A1 Zeng, Daniel Dajun
YR 2020
UL http://medrxiv.org/content/early/2020/02/09/2020.02.07.20021071.abstract
AB Estimating the key epidemiological features of the novel coronavirus (2019-nCoV) epidemic proves to be challenging, given incompleteness and delays in early data reporting, in particular, the severe under-reporting bias in the epicenter, Wuhan, Hubei Province, China. As a result, the current literature reports widely varying estimates. We developed an alternative geo-stratified debiasing estimation framework by incorporating human mobility with case reporting data in three stratified zones, i.e., Wuhan, Hubei Province excluding Wuhan, and mainland China excluding Hubei. We estimated the latent infection ratio to be around 0.12% (18,556 people) and the basic reproduction number to be 3.24 in Wuhan before the city’s lockdown on January 23, 2020. The findings based on this debiasing framework have important implications to prioritization of control and prevention efforts.One Sentence Summary A geo-stratified debiasing approach incorporating human movement data was developed to improve modeling of the 2019-nCoV epidemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by grants from the Ministry of Science and Technology (2016QY02D0305), National Natural Science Foundation of China (71621002, 71771213, 71790615, 71972164 and 91846301), Chinese Academy of Sciences (ZDRW-XH-2017-3), and the Hunan Science and Technology Plan Project (2017RS3040, 2018JJ1034).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe human movement data is not available for sharing due to the constraint in the consent. All other data is available in the main text or the supplementary materials.